AUTL Competitors & Alternatives
Compare Autolus Therapeutics Ltd with similar stocks in the same industry
Biotechnology
AUTL
Main Stock$1.57
Tradestie Score
58
Market Cap
$444.46M
Revenue Growth
836.6%
Analyst Upside
+452.7%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABSI
Absci Corporation Common Stock
|
$5.90
|
$468.01M | - | 54 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$19.39
|
$463.20M | - | 59 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$7.27
|
$457.09M | - | 54 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$4.85
|
$454.29M | - | 59 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 53 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$17.06
|
$448.32M | - | 56 | Compare |
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 58 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$23.66
|
$422.50M | - | 54 | Compare |
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$85.50
|
$410.79M | - | 57 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$10.14
|
$407.71M | - | 60 | Compare |
More AUTL Analysis
Data updated: May 08, 2026 | Industry: Biotechnology (SIC 2836)
228 stocks in this industry